Cargando…
Inhaled Corticosteroids and COVID-19 Risk and Mortality: A Nationwide Cohort Study
Inhaled corticosteroids (ICS) could increase both the risk of coronavirus disease 2019 (COVID-19) and experiencing poor outcomes. To compare the clinical outcomes between ICS users and nonusers, COVID-19-related claims in the Korean Health Insurance Review and Assessment database were evaluated. To...
Autores principales: | Choi, Jae Chol, Jung, Sun-Young, Yoon, Una A., You, Seung-Hun, Kim, Myo-Song, Baek, Moon Seong, Jung, Jae-Woo, Kim, Won-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690894/ https://www.ncbi.nlm.nih.gov/pubmed/33114246 http://dx.doi.org/10.3390/jcm9113406 |
Ejemplares similares
-
COVID-19-related outcomes in immunocompromised patients: A nationwide study in Korea
por: Baek, Moon Seong, et al.
Publicado: (2021) -
Association of Renin-angiotensin-aldosterone System Inhibitors With Coronavirus Disease 2019 (COVID-19)- Related Outcomes in Korea: A Nationwide Population-based Cohort Study
por: Jung, Sun-Young, et al.
Publicado: (2020) -
Addition of Montelukast to Low-Dose Inhaled Corticosteroid Leads to Fewer Exacerbations in Older Patients Than Medium-Dose Inhaled Corticosteroid Monotherapy
por: Ye, Young-Min, et al.
Publicado: (2015) -
Inhaled budesonide for early treatment of COVID-19
por: Choi, Jae Chol, et al.
Publicado: (2021) -
Efficacy and predictors of response to inhaled corticosteroid treatment for chronic cough
por: Hong, Ji Young, et al.
Publicado: (2019)